During last quarter, the Chamber of Commerce of the USA

lobbied for the intellectual property issues related to India and other countries, as also for Bilateral Investment Treaty negotiations with India, Indo-US economic relations, India's cyber security, and US-India commercial and trade ties. Pfizer, on the other hand, lobbied on issues relating to an Indian Supreme Court decision on generic medicine pricing and issues relating to cancellation of patent in India. Other entities having lobbied for India-related issues earlier in 2012 included computer maker HP, telecom firm Qualcomm, financial services majors like Morgan Stanley and Prudential Financial, as also lobby groups like Financial Executives International, Business Roundtable and Financial Services Forum, as well as consumer goods maker Cargill Inc. Giants like Boeing, AT&T, Starbucks, Lockheed Martin, Eli Lilly and GE have also lobbied in previous years with US lawmakers on "specific lobbying issues" related to India, which include discussions on market opening initiatives and support for sales and business opportunities in the country. One of the most active entities with India-related lobbying issues in 2012 was Alliance of Automobile Manufacturers with its opposition to the regulation of carbon dioxide emissions in the US until India along with China and Russia implement similar reductions. Besides, insurance major Prudential Financial has been lobbying for "Indian financial market access and equity ownership issues". Like the government decision to open FDI in retail, a proposal to increase FDI cap in insurance sector is also being vehemently opposed by various political parties.